COVID-19

Survey: Chief Nursing Officers View Virtual Nursing as Integral to Care

Improved nurse satisfaction and retention cited by CNOs as top reason to implement virtual nursing solutions, AvaSure-Joslin Insight survey reveals…

2 years ago

Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award

Company Named "Best Cell & Gene Therapy Supplier – Cryogenic Storage" NASHVILLE, Tenn., Sept. 14, 2023 /PRNewswire/ -- Cryoport, Inc.…

2 years ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union

The positive opinion follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines for…

2 years ago

Rencofilstat Produces Positive Outcomes in Translational Study on Idiopathic Pulmonary Fibrosis

– Proteomics analysis showed that rencofilstat improved aberrant protein profiles in IPF tissues – – Superior effects of rencofilstat alone…

2 years ago

ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences

Scientific Abstracts and Presentations Feature New and Additional Data Demonstrating the Efficacy, Effectiveness, and Safety of ProSomnus Precision Devices for…

2 years ago

BetterLife Pharma to Host Investors Update Call on September 18, 2023

VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF…

2 years ago

Tonix Pharmaceuticals Announces Poster Presentation Involving TNX-1700 in Preclinical Colorectal Cancer Models at the Seventh International Cancer Immunotherapy Conference 2023

CHATHAM, N.J., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage…

2 years ago

Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943

Phase 1 trial enrolling patients with relapsed/refractory AML, MDS and B-cell ALLPALO ALTO, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) --…

2 years ago